Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genkinakaigo CoTSE:599A EBITDA Margin % is 5.47% as of Dec. 2025, which is 21% below its 10-year median of 6.93. The stock has 1 warning sign investors should review. Among 663 Healthcare Providers & Services companies, Genkinakaigo Co ranks worse than 63.35% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Genkinakaigo Co's EBITDA for the
six
months ended in Dec. 2025 was 円282 Mil. Genkinakaigo Co's Revenue for the
six
months ended in Dec. 2025 was 円5,150 Mil. Therefore, Genkinakaigo Co's EBITDA margin for the quarter that ended in Dec. 2025 was 5.47%.
Genkinakaigo Co (TSE:599A) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Genkinakaigo Co EBITDA Margin % Related Terms
Genkinakaigo Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Genkinakaigo Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genkinakaigo Co EBITDA Margin % Chart
Genkinakaigo Co Annual Data
Trend
Jun24
Jun25
EBITDA Margin %
8.48
5.38
Genkinakaigo Co Semi-Annual Data
Jun24
Jun25
Dec25
EBITDA Margin %
0.00
0.00
5.47
TSE:599A vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Genkinakaigo Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genkinakaigo Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genkinakaigo Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Genkinakaigo Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genkinakaigo Co (TSE:599A) has a EBITDA Margin % of 5.47% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Genkinakaigo Co and its competitors. This is 21% below median its historical median of 6.93. Over the past decade, Genkinakaigo Co's EBITDA Margin % has ranged from 5.38 to 8.48. According to the industry distribution chart, Genkinakaigo Co ranks #420 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 63.3%.
Is Genkinakaigo Co's EBITDA Margin % too high?
Genkinakaigo Co's current EBITDA Margin % of 5.47% is 21% below median its 10-year median of 6.93. Over the past 10 years, this metric has ranged from a low of 5.38 to a high of 8.48. The Healthcare Providers & Services industry median EBITDA Margin % is 10.23. Genkinakaigo Co's value of 5.47% is 46.5% below this industry median. Based on the distribution chart, Genkinakaigo Co ranks #420 out of 663 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Genkinakaigo Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Genkinakaigo Co ranks #420 out of 663 companies for EBITDA Margin %. This places Genkinakaigo Co in the lower half of its industry. The industry median EBITDA Margin % is 10.23. Genkinakaigo Co's value of 5.47% is 46.5% below this benchmark. Historically, Genkinakaigo Co's own EBITDA Margin % has ranged from 5.38 to 8.48 over the past decade. While the company's 10-year median is 6.93 vs. the industry median of 10.23, Genkinakaigo Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.23, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genkinakaigo Co's current EBITDA Margin % of 5.47% is 46.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Genkinakaigo Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genkinakaigo Co's current EBITDA Margin % is 5.47%, which is 21% below median its own 10-year median of 6.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genkinakaigo Co stock overvalued right now?
Genkinakaigo Co (TSE:599A) has a current EBITDA Margin % of 5.47%. The current EBITDA Margin % is 5.47%, which is 21% below median its 10-year median of 6.93 and 46.5% below the Healthcare Providers & Services industry median of 10.23. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Genkinakaigo Co (TSE:599A), the current EBITDA Margin % is 5.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:599A has been successfully added to your 
